Opdivo

Concentrate for solution for infusion, 10mg/ml
RxActive license

Active substance (INN)

nivolumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength10mg/ml
PackagingUkupno 1 bočica staklena sa 4ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerSwords Laboratories Unlimited Company t/a Bristol-Myers Squibb Cruiserath Biologics, Ireland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FF01)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateJanuary 11, 2023

Analogs in Montenegro

3

Other medicines with the same active substance

OpdivoRx
Concentrate for solution for infusion, 10mg/mlSwords Laboratories Unlimited Company t/a Bristol-Myers Squibb Cruiserath Biologics
OpdivoRx
Concentrate for solution for infusion, 10mg/mlSwords Laboratories Unlimited Company t/a Bristol-Myers Squibb Cruiserath Biologics
OpdivoRx
Concentrate for solution for infusion, 10mg/mlSwords Laboratories Unlimited Company t/a Bristol-Myers Squibb Cruiserath Biologics
Source: CInMED register